Skip to content

Study on tumor safety of endoscopic surgery versus traditional surgery for breast cancer

Study on tumor safety of endoscopic surgery versus traditional surgery for breast cancer

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2400094450
Enrollment
Unknown
Registered
2024-12-23
Start date
2024-12-24
Completion date
Unknown
Last updated
2025-01-06

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Breast cancer

Interventions

Endoscopic nipple-sparing mastectomy group:Endoscopic nipple-sparing mastectomy
Open mastectomy group:Open mastectomy

Sponsors

Shanghai General Hospital
Lead Sponsor

Eligibility

Sex/Gender
Female
Age
18 Years to 70 Years

Inclusion criteria

Inclusion criteria: 1. Pathologically confirmed stage I/II invasive breast cancer; 2. The size of the tumor is 3 cm from the nipple areolar area, and there is no serious axillary lymph node and vascular and nerve invasion.

Exclusion criteria

Exclusion criteria: 1. Involvement of the nipple and skin as determined by physical examination and MRI; 2. History of other cancers in the past 5 years; 3. Other serious complications such as angina, myocardial infarction, and stroke within the past 6 months; 4. Receiving immunosuppressive drugs after organ transplantation; 5. Long-term use of steroid medications; 6. Pregnant or lactating women.

Design outcomes

Primary

MeasureTime frame
Local recurrence;

Countries

China

Contacts

Public ContactMin Wang

Shanghai General Hospital

wangmin0501@hotmail.com+86 13918047806

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026